Cargando…
Treatment of sclerotic chronic graft-versus-host disease with injections of hyaluronidase
Autores principales: | Cheng, Tiffany W., Colakovic, Ryan N., Pearson, David R., Sio, Terence T., Fiessinger, Lori A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433326/ https://www.ncbi.nlm.nih.gov/pubmed/37600739 http://dx.doi.org/10.1016/j.jdcr.2023.04.032 |
Ejemplares similares
-
Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease
por: Baker, Laura X., et al.
Publicado: (2021) -
Isomorphic Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease: Report and Review of Chronic Graft-Versus-Host Disease in a Cutaneous Immunocompromised District
por: Cohen, Philip R.
Publicado: (2013) -
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease
por: Sánchez-Ortega, Isabel, et al.
Publicado: (2016) -
Sclerotic Acid
Publicado: (1878) -
Treatment of post-traumatic hematoma and fibrosis using hyaluronidase injection
por: Han, Jin Ho, et al.
Publicado: (2018)